
    
      The purpose of this study is to collect safety, tolerability, and PK data on ascending dose
      regimens of MinocinÂ® (minocycline) for Injection. The safety, tolerability, and PK data will
      support the compound as a potential clinical candidate in Europe and allow recommendations of
      dose levels to be used in future Phase 2/3 studies.
    
  